RNA, 7SL, cytoplasmic 371, pseudogene (RN7SL371P)

RN7SL371P is a pseudogene corresponding to the 7SL RNA gene family, specifically classified as a truncated, non-functional copy of the 7SL RNA involved in the signal recognition particle (SRP) complex[1][4][2]. Like other 7SL RNA pseudogenes, RN7SL371P originated from the reverse transposition of 7SL RNA back into the genome and is not transcribed into a functional or regulatory product at a detectable level[1][4]. The majority of 7SL-like sequences in the human genome are pseudogenes that do not produce active RNA or participate in SRP function[1][4][2]. Its sequence might serve as a historical marker of retrotranspositional events, but RN7SL371P itself is not a functional gene, not a receptor, enzyme, or drug target, and carries no known clinical or therapeutic significance[1][2][4]. The functional *7SL RNA* (distinct from its pseudogenes) serves as the RNA component of the signal recognition particle important for directing proteins to the endoplasmic reticulum, but *pseudogenes* like RN7SL371P are inactive "genomic fossils" and are not involved in protein synthesis or cellular signaling[1][3][4][5][6]. No evidence supports roles for RN7SL371P in disease, drug targeting, or as a clinical biomarker[1][2][4][6]. By strict nomenclature, pseudogenes such as RN7SL371P should not be considered therapeutic targets nor functional molecular entities[1][4].

Other names

RN7SL371P7SL RNA pseudogene 371